International Alliance for Biological Standardization

Select Page

SCIENTIFIC EVENTS

IABS  BIOASTER
FMT Webinar

May 24 & May 25, 2022

 

Learn more & Register

Read the meeting flyer

 

 

IABS Meeting on High Pathogenicity Avian Influenza
Vaccination Strategies to prevent and control HPAI :
Removing unnecessary barriers for usage

October 25-26, 2022

Learn more & Register

Read the meeting flyer

Globally Harmonized Specifications: Current State and Future Opportunities

September 14-15, 2022
Basel, Switzerland

Learn more & Register

Read the meeting flyer

 

 

8th Annual IABS Statistics Workshop
Advancing the Impact of CMC Statistics for a New Generation of Statisticians, Scientists, and Modelers

November 7-10, 2022

Learn more & Register

Read the meeting flyer

3rd IABS Next Generation Sequencing Conference

September 27-28, 2022
Rockville, Maryland


Learn more & Register

Read the meeting flyer

 

 

NEWS

What does IABS do that is unique ?

In this short interview, Joris Vandeputte, President of IABS has answered the question “What does IABS do that is unique ?”
To learn more about the International Alliance for Biological…

Read more

ZAPI Stakeholder Conference Report

We are pleased to let you know that the Zoonoses Anticipation and Preparedness Initiative (ZAPI) Stakeholders Conference Report (February 4 & 5, 2021) is now available.

Report available here

IABS wishes a Happy and Health New Year 2022 to all

IABS wishes a Happy and Health New Year 2022 to all. To learn more about the upcoming conference :

Upcoming events

IABS COLLABORATIONS

INNOVATIVE MEDICINES INITIATIVE (IMI) PROJECTS :

IMI is a European public-private partnership aiming to speed up the development of better and safer medicines. IMI is partly founded by the European Commission.

The IABS European Affiliate (IABS-EU) was part of consortia which have  been selected by IMI to be the public partners of following consortia.

IABS-EU was selected to drive the regulatory part of those consortia.

IABS COLLABORATIONS / MANCO, A EUROPEAN COMMISSION PROJECT :

MANCO (Monclonal Antibodies against COVID-19) is one of the eighteen projects that have been successfully selected by the European Commission, which is devoted to the development of Monoclonal Antibodies agains COVID-19.

IABES-EU was selected to drive the regulatory part of the project

TESTIMONIALS

Paul Henri Lambert

Professor at University of Geneva
Founder of ADVAC

 “I have appreciated the achievements of IABS since many years. It is a unique independent organization that can…

Read more

John Petricciani

Past President
Advisor to the Board

“ Cell substrates have been a key element in the evolution of biological products since the…

Read more

Kathryn Zoon

NIH Scientist Emeritus
Past NIAID Scientific Director

As a long term US regulator and scientist, I have been working with IABS for many years. The IABS has …

Read more

Philippe Duclos

Director ADVAC
University of Geneva

“ A vibrant organization that allows dialogue beyond professional boundaries…

Read more